POLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC) Meeting Abstract
| Authors: | Van Cutsem, E.; Golan, T.; Hammel, P.; Reni, M.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Algül, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Schlienger, K.; Locker, G. Y.; Kindler, H. L. |
| Abstract Title: | POLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz247.020 |
| Language: | English |
| ACCESSION: | WOS:000491295502123 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz247.020 |
| Notes: | Meeting Abstract: 693P -- Appears on pages v264-v265 of the abstract book -- Source: Wos |
